Items are shipped within 24 hours of purchase, unless listed as a 14-day product.

£ GBPContact

Research Use Only: All products sold by UK Sterling Peptides are intended exclusively for in vitro laboratory research. They are not for human or veterinary use, diagnosis, treatment, or consumption. Buyers are responsible for compliance with all applicable UK laws and regulations.

Retatrutide 50mg

Out of StockSKU: RT50

This item is currently unavailable.

£142.00

Research overview

Retatrutide is a synthetic peptide investigational compound designed as a triple agonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors.

It is used in laboratory receptor-binding, cell-signalling, and pharmacology assays to study incretin pathway biology. Retatrutide is not an approved pharmaceutical product and must not be used outside qualified research environments.

Scientific identity

Designation
Retatrutide
Class
Triple GIP / GLP-1 / glucagon receptor agonist (research compound)
Form
Lyophilised powder

Areas of laboratory research

  • Incretin receptor binding and signalling assays
  • Metabolic pathway research in cell lines
  • Comparative pharmacology of multi-agonist peptides
  • Bioanalytical method development (LC-MS, ELISA)

Vial contents & storage

Contents: One lyophilised research vial (50 mg), supplied for individual laboratory use.

Storage: Lyophilised material: store at ≤-20°C. If reconstituted, store at 2–8°C.

Supplied strictly for in vitro laboratory research. Not for human or veterinary administration, diagnosis, or therapeutic use.

Research Use Only: All products sold by UK Sterling Peptides are intended exclusively for in vitro laboratory research. They are not for human or veterinary use, diagnosis, treatment, or consumption. Buyers are responsible for compliance with all applicable UK laws and regulations.